Source: International Congress 2018 – New pharmacological strategies in airway diseases
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
A. URSO (New York, United States of America), V. Collico (Milan, Italy), M. Colombo (Milan, Italy), F. Meloni (Pavia, Italy), C. Damoci (New York, United States of America), G. Garcia (San Diego, United States of America), K. Sugahara (New York, United States of America), F. D'Ovidio (New York, United States of America). Late Breaking Abstract - Aerosolized gold nanoparticles as a vehicle for prolonged donor lung treatment. 515

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Do inhaled carbonaceous particles translocate from the lung to the placenta? Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 Pulmonary toxicity of cerium oxide nanoparticle following intratracheal instillation and inhalation of nanoparticles Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Late Breaking Abstract - Effects of ultrafine particles on respiratory health in adults Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep Year: 2019 Imatinib-loaded gold nanoparticles ameliorate experimental lung fibrosis induced by bleomycin Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Late Breaking Abstract: Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser therapy and physiotherapy: Implications for pandemic influenza and other airborne infections Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Efficacy of imatinib loaded-antiCD44 coated gold nanoparticles: a possible new therapeutic approach to BOS Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Late Breaking Abstract - Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract: Comparison of bioavailability of two zanamivir inhalation powder formulations in healthy subjects Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Effect of N-acetylcysteine loaded in biocompatible nanoparticle on lipopolysaccharide-induced acute lung injury model in rats Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology Year: 2020 Late Breaking Abstract - The efficacy of roflumilast in the treatment of COPD(stage B). Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Short duration high intensity intrapleural Alteplase with Pulmozyme in pleural infection management – a single centre experience Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Combinatorial delivery of targeted mesoporous silica nanoparticles for lung cancer therapy Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Late Breaking Abstract - Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009